AstraZeneca to Invest $245 Million in Deal With Cellectis

By Ben Otto British drugmaker AstraZeneca plans to invest $245 million in a deal with biotechnology company Cellectis to develop next-generation therapeutics...

Related Keywords

United Kingdom ,British ,Ben Otto ,Astrazeneca ,Paris Based Cellectis ,Article Normal ,Biotechnology Services ,Pharmaceuticals ,Healthcare Life Sciences ,Biopharmaceuticals ,Research Development ,Corporate Industrial News ,Synd ,Cellectis ,Alcls Fr ,Fr Alcls ,Azn Ln ,Uk Azn ,Azn ,Gb0009895292 ,Us0463531089 ,Fr0010425595 ,Us15117k1034 ,Clls ,Research ,Development ,Corporate ,Industrial News ,Healthcare ,Life Sciences ,